Claudia Henschke received the IASLC 2024 Joseph W. Cullen Prevention/Early Detection Award

Lung Cancer Policy Network shared a post by I-ELCAP on LinkedIn, adding:

“Huge congratulations to Network member Claudia Henschke and the entire team at the International Early Lung Cancer Action Program (I-ELCAP) for receiving the IASLC 2024 Joseph W. Cullen Prevention/Early Detection Award!

I-ELCAP has played a pivotal role in transforming the way we diagnose and treat lung cancer, setting the standard for how modern lung cancer screening programmes are developed and implemented.

The programme’s groundbreaking low-dose computed tomography scan (LDCT) screening protocol has been instrumental in detecting lung cancer at its earliest stages, leading to major changes in global screening guidelines and significantly improving patient outcomes.

Well done to Claudia and the I-ELCAP team for this well-deserved recognition!”

Quoting I-ELCAP‘s post:

“Exciting news! A huge congratulations to Dr. Claudia Henschke for being honored with the prestigious Joseph W. Cullen Prevention/Early Detection Award at WCLC2024. Well-deserved for her groundbreaking work in Lung Cancer Screening and Early Detection!”

Source: Lung Cancer Policy Network/LinkedIn and I-ELCAP/LinkedIn

More posts about WCLC24 on oncodaily.com

Dr. Claudia Henschke is a Professor of Radiology at Mount Sinai School of Medicine and leads the Lung and Cardiac Screening Program at Mount Sinai Medical Center. She also directs the International Early Lung Cancer Action Program (I-ELCAP), a global collaboration of experts focused on lung cancer. Prior to her role at Mount Sinai, Dr. Henschke was a Professor of Radiology at Weill Cornell Medical College.